Thus, in vitro and in vivo findings indicate that METTL3 knockdown could ameliorate LPS-induced mouse intestinal epithelial cell inflammation and apoptosis and DSS-induced IBD. This evidence concerns the gene METTL3 and inflammatory bowel disease.